Llwytho...
CELLULAR AND MOLECULAR IMMUNOLOGY OF LUNG CANCER: THERAPEUTIC IMPLICATIONS
Though incidence is declining, the prognosis of lung cancer remains poor. This is likely due to lack of early detection and only recent developments in selective cancer therapies. Key immune cells involved in the pathogenesis of lung cancer include CD4(+) T-lymphocytes, macrophages, dendritic cells,...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Expert Rev Clin Immunol |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2014
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4596236/ https://ncbi.nlm.nih.gov/pubmed/25351434 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/1744666X.2014.975692 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|